Health Trials

Frequency of Metabolic Dysfunction Associated Fatty Liver Disease in Patients With Acute Coronary Syndromes

ConditionFatty Liver
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorAssiut University

About this trial

Aim of the research is to assess frequency of MAFLD among patients with acute coronary syndromes (ACS).

Eligibility criteria

Qualifiers

None

Disqualifiers

Patients refused to participate.

Patients with history of alcohol or drug abuse.

Patients have hepatitis C or hepatitis B infection.

Patients have primary or secondary hepatic malignancies

Trial design

Treatments tested in this trial

  • fibroscan

Treatment groups

No treatment groups listed

Locations

This trial has no locations

Sponsors and collaborators

Assiut University

Lead sponsor

Source ClinicalTrials.gov